Instituto Rosenbusch S.A. (BCBA:ROSE)

Instituto Rosenbusch Statistics

Total Valuation

BCBA:ROSE has a market cap or net worth of ARS 6.86 billion. The enterprise value is 8.39 billion.

Market Cap	6.86B
Enterprise Value	8.39B

Important Dates

The next estimated earnings date is Wednesday, December 24, 2025.

Earnings Date	Dec 24, 2025
Ex-Dividend Date	n/a

Share Statistics

BCBA:ROSE has 42.59 million shares outstanding.

Current Share Class	42.58M
Shares Outstanding	42.59M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	80.05%
Owned by Institutions (%)	n/a
Float	8.50M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.37
PB Ratio	3.98
P/TBV Ratio	4.57
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-2.55
EV / Sales	1.68
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-13.94

Financial Position

The company has a current ratio of 1.35, with a Debt / Equity ratio of 1.34.

Current Ratio	1.35
Quick Ratio	0.70
Debt / Equity	1.34
Debt / EBITDA	n/a
Debt / FCF	-3.83
Interest Coverage	-2.94

Financial Efficiency

Return on equity (ROE) is -122.94% and return on invested capital (ROIC) is -18.76%.

Return on Equity (ROE)	-122.94%
Return on Assets (ROA)	-11.78%
Return on Invested Capital (ROIC)	-18.76%
Return on Capital Employed (ROCE)	-41.59%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.70
Inventory Turnover	1.81

Taxes

In the past 12 months, BCBA:ROSE has paid 145.01 million in taxes.

Income Tax	145.01M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +69.47% in the last 52 weeks. The beta is -0.09, so BCBA:ROSE's price volatility has been lower than the market average.

Beta (5Y)	-0.09
52-Week Price Change	+69.47%
50-Day Moving Average	155.14
200-Day Moving Average	150.82
Relative Strength Index (RSI)	64.78
Average Volume (20 Days)	120,320

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BCBA:ROSE had revenue of ARS 5.01 billion and -3.30 billion in losses. Loss per share was -77.41.

Revenue	5.01B
Gross Profit	355.70M
Operating Income	-1.36B
Pretax Income	-3.18B
Net Income	-3.30B
EBITDA	-1.22B
EBIT	-1.36B
Loss Per Share	-77.41

Balance Sheet

The company has 991.84 million in cash and 2.30 billion in debt, giving a net cash position of -1.31 billion or -30.82 per share.

Cash & Cash Equivalents	991.84M
Total Debt	2.30B
Net Cash	-1.31B
Net Cash Per Share	-30.82
Equity (Book Value)	1.72B
Book Value Per Share	35.20
Working Capital	1.45B

Cash Flow

In the last 12 months, operating cash flow was -594.40 million and capital expenditures -7.55 million, giving a free cash flow of -601.95 million.

Operating Cash Flow	-594.40M
Capital Expenditures	-7.55M
Free Cash Flow	-601.95M
FCF Per Share	-14.13

Margins

Gross margin is 7.11%, with operating and profit margins of -27.10% and -65.86%.

Gross Margin	7.11%
Operating Margin	-27.10%
Pretax Margin	-63.54%
Profit Margin	-65.86%
EBITDA Margin	-24.29%
EBIT Margin	-27.10%
FCF Margin	n/a

Dividends & Yields

BCBA:ROSE does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-48.08%
FCF Yield	-8.78%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on November 16, 2011. It was a forward split with a ratio of 1.43614361.

Last Split Date	Nov 16, 2011
Split Type	Forward
Split Ratio	1.43614361

Scores

BCBA:ROSE has an Altman Z-Score of -0.22 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.22
Piotroski F-Score	1